Jasper Therapeutics, Inc.
JSPR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001788028
No open-market purchases or sales by Jasper Therapeutics, Inc. insiders were filed in the last 90 days; 45 institutions reported holding it in 13F filings for Q2 2026, worth $5.05M in total; no superinvestor holds it.
Other share classesJSPRW
13F holders, Q1 2022
Institutional positions in Jasper Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- 0 vs. Q4 2021
- Shares held
- 20.1M
- −612.5K (−3.0%) vs. Q4 2021
- Total value
- $69.6M
- −$89.3M (−56.2%) vs. Q4 2021
- New holders
- 6
- 3 more added
- Sold out
- 6
- 7 more reduced
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JSPR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $5.05M |
| Q1 2026 | 58 | $13.9M |
| Q4 2025 | 55 | $35.2M |
| Q3 2025 | 60 | $47.8M |
| Q2 2025 | 65 | $69.5M |
| Q1 2025 | 69 | $56.1M |
| Q4 2024 | 88 | $334.5M |
| Q3 2024 | 81 | $274.8M |
| Q2 2024 | 69 | $329.8M |
| Q1 2024 | 61 | $380.2M |
| Q4 2023 | 42 | $61.2M |
| Q3 2023 | 41 | $63.7M |
| Q2 2023 | 46 | $120.0M |
| Q1 2023 | 45 | $168.8M |
| Q4 2022 | 23 | $9.57M |
| Q3 2022 | 23 | $15.7M |
| Q2 2022 | 23 | $37.5M |
| Q1 2022 | 24 | $69.6M |
| Q4 2021 | 25 | $160.7M |
| Q3 2021 | 9 | $101.4M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Jasper Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 5,852,982 | $20.8M | 19.52% | 00.0% | Unchanged |
| Abingworth LLP | 5,628,558 | $19.5M | 5.54% | 00.0% | Unchanged |
| Citadel Advisors LLC | 2,994,580 | $10.6M | 0.01% | −51,576−1.7% | Reduced |
| Velan Capital Investment Management LP | 3,219,036 | $10.2M | 9.45% | 00.0% | Unchanged |
| Sectoral Asset Management Inc | 675,000 | $2.40M | 0.43% | +675,000 | New |
| Kingdon Capital Management, L.L.C. | 540,000 | $1.92M | 0.33% | 00.0% | Unchanged |
| Vanguard Group Inc | 477,824 | $1.70M | 0.00% | −5,679−1.2% | Reduced |
| Federated Hermes, Inc. | 251,697 | $894.0K | 0.00% | −954,880−79.1% | Reduced |
| BlackRock Inc. | 169,569 | $603.0K | 0.00% | +760.0% | Added |
| Geode Capital Management, LLC | 127,734 | $453.0K | 0.00% | +10,684+9.1% | Added |
| Forefront Analytics, LLC | 32,550 | $118.0K | 0.04% | +32,550 | New |
| BIT Capital GmbH | 30,000 | $106.5K | 0.01% | +30,000 | New |
| State Street Corp | 21,752 | $77.0K | 0.00% | +21,752 | New |
| Northern Trust Corp | 20,289 | $72.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 10,871 | $39.0K | 0.00% | +10,871 | New |
| Goldman Sachs Group Inc | 10,451 | $37.0K | 0.00% | −7,298−41.1% | Reduced |
| Vahanian & Associates Financial Planning Inc. | 10,000 | $36.0K | 0.08% | −15,000−60.0% | Reduced |
| Morgan Stanley | 4,276 | $15.0K | 0.00% | −294,513−98.6% | Reduced |
| Penserra Capital Management LLC | 4,403 | $15.0K | 0.00% | +1,676+61.5% | Added |
| Tower Research Capital LLC (TRC) | 1,355 | $5.00K | 0.00% | −1,559−53.5% | Reduced |
| Highbridge Capital Management LLC | 741 | $3.00K | 0.00% | +741 | New |
| Wells Fargo & Company | 251 | $1.00K | 0.00% | 00.0% | Unchanged |
| Ionic Capital Management LLC | 100 | $0 | 0.00% | 00.0% | Unchanged |
| SkyView Investment Advisors, LLC | 5 | $0 | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 0 | $0 | 0.00% | −20,743−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −19,922−100.0% | Sold out |
| Truist Financial Corp | 0 | $0 | 0.00% | −11,250−100.0% | Sold out |
| Paloma Partners Management Co | 0 | $0 | 0.00% | −10,141−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −2,552−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −700−100.0% | Sold out |
| Grace Capital | – | – | – | – | Not filed |